Drug intelligence / Profile preview

CP2b-GNS

Development stage: Preclinical
Lead developer: Government College University Faisalabad
Modality: Hydrogel Systems → Drug Delivery Systems

Overview

CP2b-GNS is a hydrogel-based drug delivery system composed of graphene sheets (GNS), polyvinyl alcohol (PVA), and chitosan (CS). It is designed to enhance drug effectiveness, particularly for methotrexate (MTX) delivery in cancer treatment. The hydrogel exhibits pH-responsive and thermosensitive properties, which allow for controlled drug release. It also shows antibacterial activity and is hemocompatible.

Other names: CP2b-GNSCP-2b-GNSCP 2b-GNS

Targets

Nucleotide synth (Nucleotide synthesis enzymes)

Beyond the preview

Go deeper on CP2b-GNS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CP2b-GNS.

Explore the full profile